Drug intelligence / Profile preview

interleukin-4-inducing principle of Schistosoma mansoni eggs

Development stage
Preclinical
Lead developer
Children's National Hospital
Modality
Recombinant Proteins and Enzymes
Administration
Intravesical, Intravenous
01

Overview

Interleukin-4-inducing principle of Schistosoma mansoni eggs (IPSE), also known as alpha-1, is a major immunomodulatory glycoprotein secreted by the eggs of the parasitic flatworm *Schistosoma mansoni* (and its homolog H-IPSE from *Schistosoma haematobium*). IPSE acts as an immunoglobulin-binding factor with high affinity for IgE. By binding to IgE on the surface of basophils and mast cells, it triggers the release of interleukin-4 (IL-4) and interleukin-13 (IL-13), promoting a T-helper 2 (Th2) anti-inflammatory response and the differentiation of alternatively activated (M2) macrophages. Additionally, IPSE contains a nuclear localization sequence (NLS) that allows it to function as an 'infiltrin,' translocating into host cell nuclei to modulate gene transcription. IPSE is being investigated in preclinical studies for its therapeutic potential in treating chemotherapy-induced hemorrhagic cystitis, bladder pain/hypersensitivity, bacterial urinary tract infections, type 1 diabetes, and sepsis.

Other names
H-IPSEIPSEIPSE/alpha-1M-IPSEalpha-1alpha1alpha 1interleukin-4-inducing principle of Schistosoma eggsinterleukin4-inducing principle of Schistosoma eggsinterleukin 4-inducing principle of Schistosoma eggs
02

Targets

DNAIgE (Immunoglobulin E)IL8 (C-X-C Motif Chemokine Ligand 8)

Beyond the preview

Go deeper on interleukin-4-inducing principle of Schistosoma mansoni eggs.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on interleukin-4-inducing principle of Schistosoma mansoni eggs.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call